Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study

Background: Although epidemiological studies have reported positive associations between circulating urate levels and cardiometabolic diseases, causality remains uncertain.

Objectives: Through a Mendelian randomization approach, we assessed whether serum urate levels are causally relevant in type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), ischemic stroke, and heart failure (HF).

Methods: This study investigated 28 single nucleotide polymorphisms known to regulate serum urate levels in association with various vascular and nonvascular risk factors to assess pleiotropy. To limit genetic confounding, 14 single nucleotide polymorphisms exclusively associated with serum urate levels were used in a genetic risk score to assess associations with the following cardiometabolic diseases (cases/controls): T2DM (26,488/83,964), CHD (54,501/68,275), ischemic stroke (14,779/67,312), and HF (4,526/18,400). As a positive control, this study also investigated our genetic instrument in 3,151 gout cases and 68,350 controls.

Results: Serum urate levels, increased by 1 SD due to the genetic score, were not associated with T2DM, CHD, ischemic stroke, or HF. These results were in contrast with previous prospective studies that did observe increased risks of these 4 cardiometabolic diseases for an equivalent increase in circulating urate levels. However, a 1 SD increase in serum urate levels due to the genetic score was associated with increased risk of gout (odds ratio: 5.84; 95% confidence interval: 4.56 to 7.49), which was directionally consistent with previous observations.

Conclusions: Evidence from this study does not support a causal role of circulating serum urate levels in T2DM, CHD, ischemic stroke, or HF. Decreasing serum urate levels may not translate into risk reductions for cardiometabolic conditions.

Citing Articles

Whole exome sequence reveals genetic profiles of primary cardiomyopathy and genotype-phenotype association in Chinese population.

Liu R, Yang Y, Gong K, Wang L, Yao Y, Xie L BMC Genomics. 2025; 26(1):150.

PMID: 39962380 PMC: 11834636. DOI: 10.1186/s12864-025-11323-4.

Associations of Serum Urate and Cardiovascular Events in a Clinical Trial of Interleukin-1β Blockade.

Adamstein N, MacFadyen J, Weber B, Libby P, Solomon D, Ridker P JACC Adv. 2025; 4(3):101583.

PMID: 39862678 PMC: 11803220. DOI: 10.1016/j.jacadv.2024.101583.

Influence of Uric Acid on Vascular and Cognitive Functions: Evidence for an Ambivalent Relationship.

Baratta F, Moscucci F, Ettorre E, Bocale R, Cicero A, Cirillo P Metabolites. 2024; 14(11).

PMID: 39590878 PMC: 11596799. DOI: 10.3390/metabo14110642.

Association of Serum Uric Acid with Indices of Insulin Resistance: Proposal of a New Model with Reference to Gender Differences.

Liu R, Li Z, Zhang Y, Du M, Wang X, Zhang S Diabetes Metab Syndr Obes. 2024; 17:3783-3793.

PMID: 39430137 PMC: 11491090. DOI: 10.2147/DMSO.S481233.

Cardiovascular risk according to genetic predisposition to gout, lifestyle and metabolic health across prospective European and Korean cohorts.

Moon K, Jung S, Do H, Son C, Kim J, Nam Y RMD Open. 2024; 10(4).

PMID: 39379299 PMC: 11474875. DOI: 10.1136/rmdopen-2024-004552.

References

Kim S, Guevara J, Kim K, Choi H, Heitjan D, Albert D . Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 62(2):170-80. PMC: 3156692. DOI: 10.1002/acr.20065. View

Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J . Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010; 59(12):3229-39. PMC: 2992787. DOI: 10.2337/db10-0502. View

Kelkar A, Kuo A, Frishman W . Allopurinol as a cardiovascular drug. Cardiol Rev. 2011; 19(6):265-71. DOI: 10.1097/CRD.0b013e318229a908. View

Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K . Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009; 32(9):1737-42. PMC: 2732137. DOI: 10.2337/dc09-0288. View

Bhole V, De Vera M, Rahman M, Krishnan E, Choi H . Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010; 62(4):1069-76. DOI: 10.1002/art.27338. View

Voight B . MR_predictor: a simulation engine for Mendelian Randomization studies. Bioinformatics. 2014; 30(23):3432-4. DOI: 10.1093/bioinformatics/btu564. View

Saleheen D, Zaidi M, Rasheed A, Ahmad U, Hakeem A, Murtaza M . The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol. 2009; 24(6):329-38. PMC: 2697028. DOI: 10.1007/s10654-009-9334-y. View

Smith N, Felix J, Morrison A, Demissie S, Glazer N, Loehr L . Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. 2010; 3(3):256-66. PMC: 3025695. DOI: 10.1161/CIRCGENETICS.109.895763. View

Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y . Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol. 2013; 111(8):1146-51. DOI: 10.1016/j.amjcard.2012.12.034. View

10.

Tayar J, Lopez-Olivo M, Suarez-Almazor M . Febuxostat for treating chronic gout. Cochrane Database Syst Rev. 2012; 11:CD008653. PMC: 4058893. DOI: 10.1002/14651858.CD008653.pub2. View

11.

Palmer T, Lawlor D, Harbord R, Sheehan N, Tobias J, Timpson N . Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2011; 21(3):223-42. PMC: 3917707. DOI: 10.1177/0962280210394459. View

12.

Chuang S, Chen J, Yeh W, Wu C, Pan W . Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. Int J Cardiol. 2011; 154(3):316-21. DOI: 10.1016/j.ijcard.2011.06.055. View

13.

Hozawa A, Folsom A, Ibrahim H, Nieto F, Rosamond W, Shahar E . Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis. 2005; 187(2):401-7. DOI: 10.1016/j.atherosclerosis.2005.09.020. View

14.

Holme I, Aastveit A, Hammar N, Jungner I, Walldius G . Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009; 266(6):558-70. DOI: 10.1111/j.1365-2796.2009.02133.x. View

15.

Lango Allen H, Estrada K, Lettre G, Berndt S, Weedon M, Rivadeneira F . Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010; 467(7317):832-8. PMC: 2955183. DOI: 10.1038/nature09410. View

16.

Teslovich T, Musunuru K, Smith A, Edmondson A, Stylianou I, Koseki M . Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010; 466(7307):707-13. PMC: 3039276. DOI: 10.1038/nature09270. View

17.

Givertz M, Mann D, Lee K, Ibarra J, Velazquez E, Hernandez A . Xanthine oxidase inhibition for hyperuricemic heart failure patients: design and rationale of the EXACT-HF study. Circ Heart Fail. 2013; 6(4):862-8. PMC: 3902033. DOI: 10.1161/CIRCHEARTFAILURE.113.000394. View

18.

Wheeler J, Juzwishin K, Eiriksdottir G, Gudnason V, Danesh J . Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med. 2005; 2(3):e76. PMC: 1069667. DOI: 10.1371/journal.pmed.0020076. View

19.

Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T . Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One. 2009; 4(11):e7729. PMC: 2766838. DOI: 10.1371/journal.pone.0007729. View

20.

Speliotes E, Willer C, Berndt S, Monda K, Thorleifsson G, Jackson A . Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010; 42(11):937-48. PMC: 3014648. DOI: 10.1038/ng.686. View